Literature DB >> 16401275

Bayesian inferences on umbrella orderings.

Chris Hans1, David B Dunson.   

Abstract

In regression applications with categorical predictors, interest often focuses on comparing the null hypothesis of homogeneity to an ordered alternative. This article proposes a Bayesian approach for addressing this problem in the setting of normal linear and probit regression models. The regression coefficients are assigned a conditionally conjugate prior density consisting of mixtures of point masses at 0 and truncated normal densities, with a (possibly unknown) changepoint parameter included to accommodate umbrella ordering. Two strategies of prior elicitation are considered: (1) a Bayesian Bonferroni approach in which the probability of the global null hypothesis is specified and local hypotheses are considered independent; and (2) an approach which treats these probabilities as random. A single Gibbs sampling chain can be used to obtain posterior probabilities for the different hypotheses and to estimate regression coefficients and predictive quantities either by model averaging or under the preferred hypothesis. The methods are applied to data from a carcinogenesis study.

Mesh:

Substances:

Year:  2005        PMID: 16401275     DOI: 10.1111/j.1541-0420.2005.00373.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Inference for the existence of hormetic dose-response relationships in toxicology studies.

Authors:  Steven B Kim; Scott M Bartell; Daniel L Gillen
Journal:  Biostatistics       Date:  2016-02-12       Impact factor: 5.899

2.  Nonparametric bayes testing of changes in a response distribution with an ordinal predictor.

Authors:  Michael L Pennell; David B Dunson
Journal:  Biometrics       Date:  2007-08-30       Impact factor: 2.571

3.  Bayesian Local Extremum Splines.

Authors:  M W Wheeler; D B Dunson; A H Herring
Journal:  Biometrika       Date:  2017-12       Impact factor: 2.445

4.  Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.

Authors:  Yisheng Li; B Nebiyou Bekele; Yuan Ji; John D Cook
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.